Arbejdsmarkedets Tillaegspension Cuts Stock Holdings in Corteva, Inc. $CTVA

Arbejdsmarkedets Tillaegspension trimmed its position in shares of Corteva, Inc. (NYSE:CTVA) by 11.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 314,428 shares of the company’s stock after selling 38,837 shares during the quarter. Corteva accounts for 0.7% of Arbejdsmarkedets Tillaegspension’s investment portfolio, making the stock its 9th largest holding. Arbejdsmarkedets Tillaegspension’s holdings in Corteva were worth $26,321,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. J. Safra Sarasin Holding AG bought a new stake in shares of Corteva during the first quarter worth about $855,000. Procyon Advisors LLC lifted its position in Corteva by 115.8% in the 1st quarter. Procyon Advisors LLC now owns 8,874 shares of the company’s stock valued at $743,000 after acquiring an additional 4,762 shares in the last quarter. Diversify Wealth Management LLC bought a new position in Corteva in the 1st quarter valued at about $296,000. Valmark Advisers Inc. boosted its stake in Corteva by 4.0% during the 1st quarter. Valmark Advisers Inc. now owns 4,504 shares of the company’s stock valued at $377,000 after purchasing an additional 172 shares during the last quarter. Finally, Cullinan Associates Inc. boosted its stake in Corteva by 3.4% during the 1st quarter. Cullinan Associates Inc. now owns 6,067 shares of the company’s stock valued at $508,000 after purchasing an additional 200 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Corteva stock opened at $85.83 on Monday. The business’s 50 day simple moving average is $80.42 and its 200 day simple moving average is $77.61. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $87.69. The company has a market cap of $57.40 billion, a price-to-earnings ratio of 50.49, a PEG ratio of 2.62 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CTVA. Oppenheimer raised their target price on Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Barclays raised their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. The Goldman Sachs Group upped their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Citigroup raised their price target on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Finally, UBS Group cut their price target on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a report on Tuesday, June 9th. Thirteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.